• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2006-2010 年印度基孔肯雅热病毒的遗传多样性:进化动态和血清型分析。

Genetic diversity of Chikungunya virus, India 2006-2010: evolutionary dynamics and serotype analyses.

机构信息

Bharat Biotech International Ltd, Hyderabad, India.

出版信息

J Med Virol. 2012 Mar;84(3):462-70. doi: 10.1002/jmv.23187.

DOI:10.1002/jmv.23187
PMID:22246833
Abstract

The genetic diversity of Chikungunya virus (CHIKV) causing recurring outbreaks in India since 2006 was studied. The 2006 epidemic was caused by a virus strain of the East, Central and South African (ECSA) genotype with 226A in the E1 glycoprotein. The variant strain with E1-A226V mutation caused outbreaks since 2007 in the state of Kerala where Aedes albopictus is the abundant mosquito vector. Molecular epidemiology data since 2007 is scarce from other regions of the country. RT-PCR, sequencing and phylogenetic analyses of CHIKV isolates from the 2009 to 2010 epidemics in the States of Tamil Nadu and Andhra Pradesh placed them in a separate clade within the ECSA lineage. The isolates of the study had 226A in the E1 glycoprotein. The isolates had a novel E1-K211E mutation that was under significant positive selection. E1-211E is highly conserved in the Asian genotype of the virus circulated by Aedes aegypti. Unique mutations in E2 glycoprotein were identified. The two sub-lineages of ECSA genotype circulating in India parallel the abundance of Ae. albopictus and Ae. aegypti. Novel mutations in the envelope glycoproteins suggest adaptive evolution of the virus to local vector abundance. Cross neutralization of the virus isolates from recurring Indian epidemics indicated that no distinct serotypes had evolved. The study has provided insights into the origin, distribution and evolutionary adaptation of the virus to local vector abundance in the region that has reportedly, the highest incidence of CHIKV infection in the world.

摘要

自 2006 年以来,印度反复爆发基孔肯雅热(CHIKV),对其病毒的遗传多样性进行了研究。2006 年的疫情是由东非、中非和南非(ECSA)基因型病毒株引起的,其 E1 糖蛋白中的 226A 位氨基酸发生了突变。自 2007 年以来,在基孔肯雅热蚊媒丰富的喀拉拉邦,出现了携带 E1-A226V 突变的变异株引起的疫情。自 2007 年以来,来自印度其他地区的分子流行病学数据非常有限。对 2009 年至 2010 年泰米尔纳德邦和安得拉邦疫情中分离的 CHIKV 分离株进行 RT-PCR、测序和系统发育分析,发现它们位于 ECSA 谱系内的一个单独分支中。研究中的分离株在 E1 糖蛋白中具有 226A 位氨基酸。分离株具有一种新的 E1-K211E 突变,该突变受到显著的正选择。E1-211E 在埃及伊蚊传播的亚洲基因型病毒中高度保守。鉴定到 E2 糖蛋白中的独特突变。在印度流行的 ECSA 基因型的两个亚系与白纹伊蚊和埃及伊蚊的丰度平行。包膜糖蛋白中的新突变表明病毒对当地媒介丰度的适应性进化。对反复发生的印度疫情中病毒分离株的交叉中和表明,没有明显的血清型发生进化。该研究提供了对病毒起源、分布和对当地媒介丰度的进化适应的深入了解,该地区是世界上报道的基孔肯雅热感染发病率最高的地区。

相似文献

1
Genetic diversity of Chikungunya virus, India 2006-2010: evolutionary dynamics and serotype analyses.2006-2010 年印度基孔肯雅热病毒的遗传多样性:进化动态和血清型分析。
J Med Virol. 2012 Mar;84(3):462-70. doi: 10.1002/jmv.23187.
2
Molecular investigations of chikungunya virus during outbreaks in Orissa, Eastern India in 2010.2010 年印度东部奥里萨邦暴发基孔肯雅热期间的基孔肯雅病毒分子调查。
Infect Genet Evol. 2012 Jul;12(5):1094-101. doi: 10.1016/j.meegid.2012.03.012. Epub 2012 Mar 29.
3
Chikungunya virus of Asian and Central/East African genotypes in Malaysia.马来西亚的亚洲基因型和中/东非基因型基孔肯雅病毒。
J Clin Virol. 2009 Oct;46(2):180-3. doi: 10.1016/j.jcv.2009.07.016. Epub 2009 Aug 14.
4
Molecular characterization of Chikungunya virus isolates from clinical samples and adult Aedes albopictus mosquitoes emerged from larvae from Kerala, South India.从印度南部喀拉拉邦的临床样本和成年白纹伊蚊幼虫中分离出的基孔肯雅病毒分离株的分子特征。
Virol J. 2010 Aug 13;7:189. doi: 10.1186/1743-422X-7-189.
5
Origin, evolution, and phylogeography of recent epidemic CHIKV strains.近期流行的基孔肯雅病毒株的起源、演化和系统地理学。
Infect Genet Evol. 2012 Mar;12(2):392-8. doi: 10.1016/j.meegid.2011.12.015. Epub 2012 Jan 6.
6
Genetic characterization of E2 region of Chikungunya virus circulating in Odisha, Eastern India from 2010 to 2011.2010 年至 2011 年在印度东部奥里萨邦流行的基孔肯雅病毒 E2 区的遗传特征。
Infect Genet Evol. 2013 Aug;18:113-24. doi: 10.1016/j.meegid.2013.04.037. Epub 2013 May 16.
7
A226V mutation in virus during the 2007 chikungunya outbreak in Kerala, India.2007年印度喀拉拉邦基孔肯雅热疫情期间病毒发生的A226V突变。
J Gen Virol. 2008 Aug;89(Pt 8):1945-1948. doi: 10.1099/vir.0.83628-0.
8
Detection of Chikungunya virus in wild populations of Aedes albopictus in Kerala State, India.在印度喀拉拉邦白纹伊蚊野生种群中检测基孔肯雅病毒。
Vector Borne Zoonotic Dis. 2012 Oct;12(10):907-11. doi: 10.1089/vbz.2012.0969. Epub 2012 Aug 27.
9
Re-emergence of Chikungunya virus in South-east Asia: virological evidence from Sri Lanka and Singapore.东南亚基孔肯雅热病毒的再现:来自斯里兰卡和新加坡的病毒学证据。
J Gen Virol. 2010 Apr;91(Pt 4):1067-76. doi: 10.1099/vir.0.015743-0. Epub 2009 Dec 2.
10
Comparative full genome analysis revealed E1: A226V shift in 2007 Indian Chikungunya virus isolates.比较全基因组分析显示,2007年印度基孔肯雅病毒分离株中存在E1:A226V突变。
Virus Res. 2008 Jul;135(1):36-41. doi: 10.1016/j.virusres.2008.02.004. Epub 2008 Apr 1.

引用本文的文献

1
Inactivated Viral Vaccine BBV87 Protects Against Chikungunya Virus Challenge in a Non-Human Primate Model.灭活病毒疫苗BBV87在非人灵长类动物模型中可抵御基孔肯雅病毒攻击。
Viruses. 2025 Apr 10;17(4):550. doi: 10.3390/v17040550.
2
Emergence of ECSA-IOL E1-K211E/E2-V264A Lineage of Chikungunya virus during Malaysian 2021 outbreak.马来西亚 2021 年疫情中基孔肯雅病毒 ECSA-IOL E1-K211E/E2-V264A 谱系的出现。
BMC Infect Dis. 2024 Oct 24;24(1):1199. doi: 10.1186/s12879-024-10102-y.
3
The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection.
经批准的减毒活基孔肯雅病毒疫苗(IXCHIQ)引发的交叉中和抗体广度扩展至多种致关节炎甲病毒,类似于自然感染后的抗体广度。
Vaccines (Basel). 2024 Aug 7;12(8):893. doi: 10.3390/vaccines12080893.
4
Importation of a novel Indian Ocean lineage carrying E1-K211E and E2-V264A of Chikungunya Virus in Zhejiang Province, China, in 2019.2019 年中国浙江省输入性新型印度洋系虫媒病毒,携带基孔肯雅病毒 E1-K211E 和 E2-V264A。
Virus Genes. 2023 Oct;59(5):693-702. doi: 10.1007/s11262-023-02020-z. Epub 2023 Jul 19.
5
An Overview of Indian Biomedical Research on the Chikungunya Virus with Particular Reference to Its Vaccine, an Unmet Medical Need.印度关于基孔肯雅病毒的生物医学研究概述,特别提及针对该病毒的疫苗,这是一项未满足的医疗需求。
Vaccines (Basel). 2023 Jun 15;11(6):1102. doi: 10.3390/vaccines11061102.
6
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus.一个针对基孔肯雅病毒灭活病毒疫苗的获益/风险评估的布莱顿协作标准化模板,其中考虑了关键因素。
Vaccine. 2022 Aug 19;40(35):5263-5274. doi: 10.1016/j.vaccine.2022.06.006. Epub 2022 Jun 15.
7
Adaptive Evolution as a Driving Force of the Emergence and Re-Emergence of Mosquito-Borne Viral Diseases.适应进化作为蚊媒病毒性疾病出现和再现的驱动力。
Viruses. 2022 Feb 21;14(2):435. doi: 10.3390/v14020435.
8
Spread of a Novel Indian Ocean Lineage Carrying E1-K211E/E2-V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa.携带基孔肯雅病毒东非/中非/南非基因型E1-K211E/E2-V264A的新型印度洋谱系在印度次大陆、东南亚和东非的传播。
Microorganisms. 2022 Feb 3;10(2):354. doi: 10.3390/microorganisms10020354.
9
Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.新兴基孔肯雅病毒变异株在 E1-E1 糖蛋白刺突界面影响病毒附着和炎症反应。
J Virol. 2022 Feb 23;96(4):e0158621. doi: 10.1128/JVI.01586-21. Epub 2021 Dec 22.
10
Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries.基孔肯雅热病毒感染:亚洲国家的分子生物学、临床特征和流行病学。
J Biomed Sci. 2021 Dec 2;28(1):84. doi: 10.1186/s12929-021-00778-8.